Definiens Unveils Definiens XD – a new Image Analysis Platform
Complete the form below to unlock access to ALL audio articles.
Definiens, the number one Enterprise Image Intelligence™ company, has announced the introduction of a new multi-dimensional image analysis platform.
Software applications built on Definiens XD extract previously unattainable levels of volumetric and morphological intelligence from digital data. They provide scientists and clinicians with a deeper understanding of the subtle biological changes associated with disease progression and treatment, and the action and safety of new therapies.
Definiens XD fulfils formerly unmet needs, including precise and automated volumetric measurements of almost all structures and the ability to analyze virtually any multi-dimensional image data. It is the first image analysis platform to facilitate the automated comparison of images from different modalities, in-vivo and in-vitro data, 2D and 3D images over time, and two-dimensional images to three-dimensional structures in a consistent and reproducible manner.
The technology allows consistent and precise 3D volumetric measurement; the most challenging but most accurate way of measuring structures of interest, including various lesions in the human body.
Definiens XD is built upon the next generation of Definiens Cognition Network Technology®, the world’s most advanced technology for extracting intelligence from images. Developed by Gerd Binnig, the 1986 Nobel Laureate for Physics, and his team, the technology emulates human cognitive processes.
Definiens’ technology differentiates itself from pixel-based and model-based matching technologies by recognizing groups of pixels as objects, picking out shapes, colors and textures. The technology examines objects contextually and can understand scale, overlapping objects and the relationship of two-dimensional images to three-dimensional shapes.
The increasing need for multi-dimensional image analysis technologies is demonstrated by the growth of confocal and fluorescence imaging, kinetic and chemotactic assays and non-invasive imaging.
